AB
Allison Bratzel Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
85.7%
Neutral
14.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $58 |
26%
upside
| 2 | +12% |
0
%
| 4 Mar ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $100 |
35%
upside
| 4 | +18% |
0
%
| 27 Feb ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $38 |
29%
downside
| 2 | – |
–
| 6 Feb ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $84 |
51%
upside
| 1 | +0.84% |
0
%
| 6 Feb ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $110 |
8%
upside
| 2 | -4.1% |
0
%
| 6 Feb ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $4 |
326%
upside
| 1 | +9.4% |
0
%
| 6 Feb ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $14 |
56%
upside
| 2 | -8.9% |
0
%
| 5 Feb ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $4 |
153%
upside
| 1 | +3.5% |
0
%
| 5 Feb ‘26 4 months ago |
|
|
|
Neutral
Downgraded
| $0.5000 |
942%
upside
| 2 | -64% |
0
%
| 26 Jan ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $42 |
47%
upside
| 2 | +115% |
0
%
| 23 Jan ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $30 |
208%
upside
| 1 | -9.9% |
0
%
| 11 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $930 |
5%
upside
| 2 | +3.7% |
0
%
| 4 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $112 |
14%
upside
| 1 | +84% |
0
%
| 29 Jul ‘25 10 months ago |
|